Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
myFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
    Most Read
    • ‘Slow’ UK response to AstraZeneca side-effects alarms experts
    • Concerns rise about spread of coronavirus variant in London
    • Former world leaders call on Biden to suspend Covid-19 vaccine patents
    • EU bets big on BioNTech/Pfizer jab as Danes stop giving AstraZeneca
    • US signals new approach to war with Afghan withdrawal
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Biden imposes tough new sanctions on Moscow
    • Coinbase valued at $76bn in coming-of-age moment for cryptocurrency
    • Investors brace for ‘major shift’ as momentum and value collide
    • Citigroup to exit most of its Asian consumer businesses
    • Former world leaders call on Biden to suspend Covid-19 vaccine patents
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Hedge fund Elliott builds multibillion-pound stake in GlaxoSmithKline
    • Gupta carved up business empire in attempt to secure UK Covid loans
    • Citigroup to exit most of its Asian consumer businesses
    • HSBC relocates top leadership from London to Hong Kong
    • Colin vs Cuthbert: M&S takes legal action against Aldi’s caterpillar cake
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • Loose monetary policy is today’s biggest market risk
    • Further reading
    • Regulators keep watchful eye on remote workers
    • O2-Virgin Media £31bn merger cleared by UK competition watchdog
    • Global stocks have a mixed day as US earnings season kicks off
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Why we shouldn’t worry about Covid vaccine blood clots
    • Golden age of rich America’s tax evasion may be drawing to close 
    • Muddling through is Johnson’s only strategy to save the Union
    • Forget identity politics: economics is what matters now
    • Oil companies are now a more complex foe for environmentalists
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • The cross-border pitfalls of ‘working from anywhere’
    • A reading list to prepare for a post-pandemic age
    • I am 76 — should I reveal my age when applying for board positions?
    • What a bleak AI future tells us about how to work now
    • FT launches its annual business book prize
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • The vanishing billionaire: how Jack Ma fell foul of Xi Jinping
    • Why we shouldn’t worry about Covid vaccine blood clots
    • Prince Philip and the art of wearing formal clothes casually
    • Forget identity politics: economics is what matters now
    • Graphene: the holy grail of trail shoes?
  • How to Spend It
  • Sign In
  • Subscribe
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • How to Spend It
Financial Times
  • Sign In
  • Subscribe

Coronavirus treatment

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Friday, 16 April, 2021
    Covid-19 vaccines
    Pregnant women can receive Covid vaccine, say UK health chiefs

    But Joint Committee on Vaccination and Immunisation advises against using AstraZeneca shot

    new
  • Friday, 16 April, 2021
    Covid-19 vaccines
    Biden administration to allocate $1.7bn to target Covid variants

    Boost to genomic sequencing efforts comes as new strains threaten to worsen US pandemic

  • Friday, 16 April, 2021
    Covid-19 vaccines
    Mind the gap in the EU’s rich-poor vaccine divide Premium

    Vaccine disparities between rich and poor member states risk getting worse before getting better

  • Thursday, 15 April, 2021
    Covid-19 vaccines
    Pfizer chief says people will probably need yearly Covid booster

    Albert Bourla proposes ‘annual revaccination’ programme to keep virus under control

  • Thursday, 15 April, 2021
    Covid-19 vaccines
    ‘Slow’ UK response to AstraZeneca side-effects alarms experts

    Regulator’s reaction questioned after emergence of blood clots linked to vaccine

  • Thursday, 15 April, 2021
    Coronavirus pandemic
    Coronavirus: Three in four older Americans have received a Covid-19 shot - as it happened
  • Thursday, 15 April, 2021
    Covid-19 vaccines
    Norway delays AstraZeneca vaccine ruling to further probe risks

    Permanently dropping shot could affect Johnson & Johnson jab too, health minister says

  • Thursday, 15 April, 2021
    Covid-19 vaccines
    CureVac hopes to win regulatory approval for its Covid vaccine by June

    German company aims to produce up to 300m doses this year and 1bn in 2022

  • Thursday, 15 April, 2021
    Antibiotic resistance
    WHO sounds alarm on drug-resistant bacteria

    Global health body warns none of antibiotics currently being developed are enough to tackle superbugs

  • Promoted Content
  • Wednesday, 14 April, 2021
    Covid-19 vaccines
    J&J vaccine pause to last extra week amid blood clot fears

    Guidance that jab should not be used remains in place after US meeting of experts

  • Wednesday, 14 April, 2021
    Coronavirus pandemic
    Coronavirus: US panel needs more data to decide on restart of J&J vaccine - as it happened
  • Wednesday, 14 April, 2021
    Covid-19 vaccines
    Former world leaders call on Biden to suspend Covid-19 vaccine patents

    Gordon Brown one of 175 figures urging action to boost inoculation rates in the developing world

  • Wednesday, 14 April, 2021
    UK social care
    Mandatory vaccines move closer for UK care home staff

    Rapid consultation begun by health department after findings that not enough institutions reaching safe jab threshold

  • Wednesday, 14 April, 2021
    Covid-19 vaccines
    EU bets on BioNTech/Pfizer jab as Danes stop giving AstraZeneca

    Brussels puts focus on mRNA vaccines amid concern over rare blood clots linked to other shots

  • Wednesday, 14 April, 2021
    Pound Sterling
    Pound cools against dollar and euro as Covid vaccines boost wears off

    Sterling slips after posting sharp gains early in 2021

  • Wednesday, 14 April, 2021
    Covid-19 vaccines
    AstraZeneca vaccine elicits stronger T-cell response in elderly than Pfizer jab

    Study adds to evidence in favour of spacing out doses to fight Covid

  • Wednesday, 14 April, 2021
    Undercover EconomistTim Harford
    Why we shouldn’t worry about Covid vaccine blood clots

    ‘For the entire winter wave, one day’s delay to being vaccinated has been riskier than vaccine itself’

  • Wednesday, 14 April, 2021
    Global InsightDaniel Dombey
    Political polarisation hampers Spain’s pandemic response

    Prime minister Sánchez at odds with Madrid regional chief over lockdowns and vaccine policy

  • Wednesday, 14 April, 2021
    Covid-19 vaccines
    J&J vaccine pause threatens to dent public confidence, warn experts

    Recommendation to halt use of one-dose jab in US risks stoking hesitancy towards other shots

  • Wednesday, 14 April, 2021
    News in-depthIndian politics & policy
    India seeks vaccine boost with Russian jab deal as Covid cases soar

    Experts warn Sputnik V production will not alleviate shortages as most doses destined for export

  • Tuesday, 13 April, 2021
    Covid-19 vaccines
    Can mixing Covid vaccines work?

    Scientists are testing the risks and advantages of offering a different shot for second and third doses

  • Tuesday, 13 April, 2021
    Coronavirus pandemic
    Coronavirus: Pfizer expects to meet US supply target ahead of schedule as authorities halt use of J&J shot - as it happened
  • Tuesday, 13 April, 2021
    Covid-19 vaccines
    J&J delays vaccine rollout in Europe after US health agencies call for pause

    CDC and FDA recommendation comes after reports of ‘rare and severe’ blood clots

  • Tuesday, 13 April, 2021
    Valerie Hopkins
    Bounty of Serbian vaccine diplomacy shames the EU

    Belgrade’s purchase of Chinese, Russian and western jabs also recalls non-aligned movement’s golden days

  • Tuesday, 13 April, 2021
    Surge testing launched in south London for variant outbreak

    Forty-four cases are confirmed of the strain first detected in South Africa

Previous You are on page 1 Next

Recommended

Covid-19 vaccines
Covid-19 vaccine tracker: the global race to vaccinate
Covid-19 vaccines
Covid vaccine development: The shots available and the doses administered
Covid-19 vaccines
In graphics: the UK vaccine supply chain
Coronavirus: free to read
Coronavirus tracker: the latest figures as countries fight the Covid-19 resurgence

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

FT LiveShare News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingContracts & Tenders
Executive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School Rankings
Enterprise ToolsNews feedNewslettersCurrency Converter
More from the FT Group
Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2021. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • How to Spend It
  • Special Reports
  • FT recommends
  • Graphics
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In